Hasil Filter

15718

Total database: 17430
Struktur (SMILES)
10762 (68.5%)
Target
7957 (50.6%)
Genomik
112 (0.7%)
Referensi
15718 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (15718)

Halaman 103 / 315
CRA_17693 DB01741
small molecule

Deskripsi belum tersedia.

Target Protein:
Serine protease 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CRA_1801 DB03016
small molecule

Deskripsi belum tersedia.

Target Protein:
Serine protease 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CRA_1802 DB02875
small molecule

Deskripsi belum tersedia.

Target Protein:
Serine protease 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CRA_8696 DB03159
small molecule

Deskripsi belum tersedia.

Target Protein:
ProthrombinUrokinase-type plasminogen activatorSerine protease 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CRA_9076 DB04215
small molecule

Deskripsi belum tersedia.

Target Protein:
Serine protease 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Creatine Approved DB00148
small molecule | CAS: 57-00-1

An amino acid derivative that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as creatinine in the urine.

Kategori:
AmidinesAmino AcidsAmino Acids, Peptides, and Proteins +3
Target Protein:
Creatine kinase M-typeCreatine kinase U-type, mitochondrialCreatine kinase B-type +3
Waktu Paruh3 hours
Vol. Distribusi-
Klirens-
Genetik -
Creatinine DB11846
small molecule | CAS: 60-27-5

Creatinine has been used in trials studying the treatment of Amyotrophic Lateral Sclerosis.

Kategori:
Imidazoles
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 6903-79-3

COP is under investigation for the treatment of Rheumatoid Arthritis, Mature B-Cell Lymphoma, and Noninflammatory Degenerative Joint Disease. COP has been investigated for the treatment of Diabetic Retinopathy.

Kategori:
Cardiac Therapy
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Crefmirlimab DB17577
biotech | CAS: 2611099-93-3

Crefmirlimab is an anti-human CD8 probe targeting the CD8 antigen, for the diagnosis of various cancers.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Crenezumab DB11959
biotech | CAS: 1095207-05-8

Crenezumab has been used in trials studying the treatment of Alzheimer's Disease.

Kategori:
Alzheimer Disease, drug therapyAmino Acids, Peptides, and ProteinsAntibodies +8
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Crenolanib DB11832
small molecule | CAS: 670220-88-9

Crenolanib is under investigation for the treatment of Diffuse Intrinsic Pontine Glioma and Progressive or Refractory High-Grade Glioma.

Kategori:
Antineoplastic AgentsHeterocyclic Compounds, Fused-RingReceptor, Platelet-Derived Growth Factor alpha, antagonists & inhibitors +2
Target Protein:
Platelet-derived growth factor receptor alphaProto-oncogene tyrosine-protein kinase Src
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cresol Approved DB11143
small molecule | CAS: 1319-77-3

Cresol is a hydroxytoluene that can be extracted naturally from coal tar or made synthetically. Pure cresol is a mixture of ortho-, meta-, and para- isomers. Cresols are precursors or synthetic intermediates to various other compounds and materials, including…

Kategori:
Benzene DerivativesDrugs that are Mainly Renally ExcretedPhenols +1
Waktu ParuhThere does not appe…
Vol. DistribusiOne study determine…
KlirensAs colonic microbia…
Genetik -
Cridanimod DB13674
small molecule | CAS: 38609-97-1

Deskripsi belum tersedia.

Kategori:
Adjuvants, ImmunologicAntineoplastic and Immunomodulating AgentsHeterocyclic Compounds, Fused-Ring +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Crinecerfont DB18518
small molecule | CAS: 752253-39-7

Deskripsi belum tersedia.

Kategori:
Sulfur Compounds
Target Protein:
Corticotropin-releasing factor receptor 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Crisaborole Approved DB05219
small molecule | CAS: 906673-24-3

Crisaborole is a novel oxaborole approved by FDA on December 14, 2016 as Eucrisa, a topical treatment of for mild to moderate atopic dermatitis. This non-steroidal agent is efficacious in improving disease severity, reducing the risk of infection and reduci…

Kategori:
Agents for Dermatitis, Excluding CorticosteroidsAnti-Inflammatory AgentsCytochrome P-450 CYP2B6 Inhibitors +9
Target Protein:
3',5'-cyclic-AMP phosphodiesterase 4A3',5'-cyclic-AMP phosphodiesterase 4B3',5'-cyclic-AMP phosphodiesterase 4C +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Crisdesalazine DB18405
small molecule | CAS: 927685-43-6

Deskripsi belum tersedia.

Kategori:
Anti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalBenzene Derivatives +3
Target Protein:
Prostaglandin E synthase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Crisugabalin DB19300
small molecule | CAS: 2209104-84-5

Crisugabalin is under investigation in clinical trial NCT06490484 (Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Crizanlizumab Approved DB15271
biotech | CAS: 1690318-25-2

Crizanlizumab is a humanized IgG2 monoclonal antibody used to reduce the frequency of vaso-occlusive crises in patients with sickle cell disease.[L10097] Sickle cell disease is a genetically inherited condition prevalent in the Middle East, Africa, and certai…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +10
Target Protein:
P-selectin
Waktu ParuhGiven a 5mg/kg dose…
Vol. DistribusiThe volume of distr…
KlirensGiven a 5mg/kg dose…
Genetik -
Crizotinib Approved DB08865
small molecule | CAS: 877399-52-5

Crizotinib is a tyrosine kinase receptor inhibitor used for the treatment of anaplastic lymphoma kinase (ALK) or ROS1-positive non-small cell lung cancer (NSCLC) tumors, as well as ALK-positive anaplastic large cell lymphoma (ALCL) and inflammatory myofibrobl…

Kategori:
AminopyridinesAnaplastic lymphoma kinase (ALK) inhibitorsAntineoplastic Agents +32
Target Protein:
ALK tyrosine kinase receptorHepatocyte growth factor receptorProto-oncogene tyrosine-protein kinase ROS +1
Waktu ParuhFollowing single do…
Vol. DistribusiFollowing a single …
KlirensAt steady-state (25…
Genetik -
Crocin DB11874
small molecule | CAS: 42553-65-1

Crocin has been investigated for the treatment of Hyperglycemia, Metabolic Syndrome, Hypertriglyceridemia, and Hypercholesterolemia.

Kategori:
AlkenesBiological FactorsCondiments +7
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Crofelemer Approved DB04941
small molecule | CAS: 148465-45-6

Crofelemer, previously known as the investigational drug SP-303, is a novel proanthocyanidin purified from the bark latex of the Amazonian Croton tree <i>Croton lechleri</i>. It is marketed under the brand name Fulyzaq and indicated for the symptomatic treatm…

Kategori:
Alimentary Tract and MetabolismAntidiarrhealsAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents +11
Target Protein:
Anoctamin-1Cystic fibrosis transmembrane conductance regulator
Waktu ParuhSince crofelemer is…
Vol. DistribusiSince crofelemer is…
KlirensSince crofelemer is…
Genetik -
Crolibulin DB12925
small molecule | CAS: 1000852-17-4

Crolibulin has been used in trials studying the treatment of Solid Tumor and Anaplastic Thyroid Cancer.

Kategori:
Heterocyclic Compounds, Fused-RingPyrans
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cromoglicic acid Approved DB01003
small molecule | CAS: 16110-51-3

A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.

Kategori:
Adrenergics, InhalantsAgents for Dermatitis, Excluding CorticosteroidsAlimentary Tract and Metabolism +24
Target Protein:
Heat shock protein HSP 90-alphaProtein S100-P
Waktu Paruh1.3 hours
Vol. Distribusi-
Klirens-
Genetik -
Cronidipine DB09233
small molecule | CAS: 113759-50-5

Cronidipine is a calcium channel blocker.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Each year it is estimated there are 45,000 snakebites in the US and 300,000 to 400,000 bites worldwide. About 8000 of these snakebites involve venomous snake species. The majority of people bitten are males and about 50% occur in the age group of 18 to 28 [F1…

Kategori:
AntiveninsPassively Acquired ImmunityVenom Neutralization
Target Protein:
Group 10 secretory phospholipase A2
Waktu Paruh12 to 23 hours [FDA…
Vol. Distribusi-
KlirensThis product was sh…
Genetik -
Crotalus atrox antivenin Approved DB13892
biotech

Each year it is estimated there are 45,000 snakebites in the US and 300,000 to 400,000 bites worldwide. About 8000 of these snakebites involve venomous snake species. The majority of people bitten are males and about 50% occur in the age group of 18 to 28 [F1…

Kategori:
AntiveninsPassively Acquired ImmunityVenom Neutralization
Waktu Paruh12-23 hours [F113]
Vol. Distribusi-
Klirens-
Genetik -
biotech

Crotalus scutulatus antivenin is derived and purified immunoglobulin fragments obtained from other domestic animals such as sheep previously immunized with Crotalus scutulatus (also known as the _Mojave rattlesnake_ [L2856]). The final purified antivenin …

Kategori:
AntiveninsPassively Acquired ImmunityVenom Neutralization
Waktu ParuhApproximately 15 ho…
Vol. Distribusi0.3 L/kg [FDA label]
Klirens32 mL/min (approxim…
Genetik -
Crotedumab DB12815
biotech | CAS: 1452387-69-7

Crotedumab has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Crotonaldehyde DB04381
small molecule | CAS: 123-73-9

Deskripsi belum tersedia.

Target Protein:
Transient receptor potential cation channel subfamily A member 1Aldehyde dehydrogenase, mitochondrial
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Crovalimab Approved DB16128
biotech | CAS: 1917321-26-6

Crovalimab is a humanized monoclonal antibody and complement C5 inhibitor.[L50908] It consists of two heavy chains (451 amino acid residues each) and two light chains (217 amino acid residues each).[L50908] First developed by Chugai Pharmaceutical, in collabo…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodies, MonoclonalAntineoplastic and Immunomodulating Agents +7
Target Protein:
Complement C5
Waktu ParuhThe mean estimated …
Vol. DistribusiThe mean central an…
KlirensIn PNH treatment-na…
Genetik -
Crozbaciclib DB18081
small molecule | CAS: 2099128-41-1

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CRS-207 DB17323
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CRS-3123 DB12262
small molecule | CAS: 1013915-71-3

CRS3123 has been used in trials studying the treatment of Clostridial Infection and Clostridium Difficile Colitis.

Kategori:
Anti-Bacterial AgentsAnti-Infective AgentsHeterocyclic Compounds, Fused-Ring +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CRx-119 DB05688
small molecule

CRx-119 is a novel synergistic combination drug candidate discovered using the CombinatoRx combination High Throughput Screening (cHTS(TM)) technology with potential therapeutic use in a broad range of immuno-inflammatory conditions. CRx-119 is a combination …

Target Protein:
Sodium-dependent serotonin transporterSodium-dependent noradrenaline transporter
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CRx-139 DB05744
small molecule

CRx-139 is an oral synergistic combination drug candidates with novel mechanisms of action targeting multiple biological pathways simultaneously. It is a dissociated steroid designed to enhance the immuno-modulatory activity of a low-dose glucocorticoid stero…

Target Protein:
Tumor necrosis factorInterleukin-6C-reactive protein +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CRx-401 DB05775
small molecule

CRx-401 is a novel insulin sensitizer designed to provide anti-diabetic activity without promoting weight gain. It consists of a low dose of the analgesic diflunisal in conjunction with a modified-release therapeutic dose of bezafibrate, an anti-cholesterol a…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cry5B DB17783
biotech

Cry5B is a pore-forming crystal protein produced by and derived from the soil bacterium _Bacillus thuringiensis_. With demonstrated anthelmintic properties, it has been investigated in the treatment of parasitic intestinal infections.[A259372, A259377]

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cryptenamine Approved DB00785
small molecule | CAS: 1356-18-9

Cryptenamine is a mixture of closely related hypotensive alkaloids from Veratrum album (Liliaceae). It has been used in the treatment of hypertension but has largely been replaced by drugs with fewer adverse effects. Cryptenamine has a marked and re-producibl…

Kategori:
AlkaloidsAntihypertensive AgentsCardiovascular Agents +3
Target Protein:
Muscarinic acetylcholine receptor M2Beta adrenergic receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 35825-57-1

Deskripsi belum tersedia.

Kategori:
Drugs, Chinese HerbalPlant Extracts
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cryptoxanthin DB15914
small molecule | CAS: 472-70-8

Deskripsi belum tersedia.

Kategori:
AlkenesBiological FactorsCarotenoids +15
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CSIC002 DB18584
small molecule

CSIC002 is a small-molecule Sema-3A inhibitor. It is being investigated for the treatment of anterior ischemic optic neuropathy.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CSL-689 DB17726
biotech

CSL689 is a recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CSL324 DB16359
biotech

CSL324 is a fully human anti-G-CSFR antibody shown to have the ability to control G-CSF-mediated neutrophilia in cynomolgus macaques.[A225626] It has potential applications in various inflammatory conditions such as cystic fibrosis, inflammatory bowel disease…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CT-001 DB18284
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CT-011 DB05916
biotech

CT-011 is a humanized monoclonal antibody directed against a B7 family-associated protein, in patients with advanced haematological malignancies. It is directed against human PD-1 (programmed cell death 1; PDCD1), with immunomodulating and antitumor activitie…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntineoplastic Agents +7
Target Protein:
Programmed cell death protein 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CT-179 DB17114
small molecule | CAS: 1996636-69-1

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CT-2584 DB13098
small molecule | CAS: 166981-13-1

CT-2584 has been used in trials studying the treatment of Prostate Cancer.

Kategori:
AlkaloidsHeterocyclic Compounds, Fused-RingPhospholipase D, antagonists & inhibitors +2
Target Protein:
Choline-phosphate cytidylyltransferase B
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 5101–5150 dari 15718
Sebelumnya Halaman 103 / 315 Berikutnya